Diagnostic and Interventional Radiology
Interventional Radiology - Original Article

Endovenous ablation with a 940 nm laser for the treatment of great saphenous vein insufficiency: short- to mid-term results


Departments of Cardiovascular Surgery, Gümüşhane State Hospital, Gümüşhane, Turkey


Department of Radiology, Bezmialem Vakıf University School of Medicine, Istanbul, Turkey


Departments of Cardiovascular Surgery, Akdeniz University School of Medicine, Antalya, Turkey


Departments of Biostatistics, Akdeniz University School of Medicine, Antalya, Turkey

Diagn Interv Radiol 2012; 18: 106-110
DOI: 10.4261/1305-3825.DIR.4234-11.2
Read: 400 Downloads: 264 Published: 03 September 2019


We aimed to present the short- to mid-term results of endovenous laser ablation (EVLA) procedures that were used to treat great saphenous vein (GSV) insufficiency.


This prospective study was conducted between December 2009 and January 2011. A total of 112 incompetent GSVs were treated using EVLA with a 940 nm wavelength laser. Ninety patients were treated for varicose veins with saphenous reflux, including 36 females (40%) and 54 males (60%). These patients' ages ranged from 17 to 79 years (median, 48 years). After the EVLA, the patients were monitored using duplex ultrasonography and were assessed clinically at 1 week and 1, 3, 6, and 12 months after the surgery. The patients were scheduled for a three-day examination after the EVLA to assess the level of pain that each patient was experiencing in each limb.


At the end of a one-year follow-up period, the postprocedural duplex scans revealed a total occlusion of the treated GSVs in 88 (97%) patients and a sub-total occlusion in two (2%) patients. The average modified clinical, etiological, anatomical, and pathological score was significantly decreased at 12 months. The following complications were observed in the present study: hypoesthesia (11%), swelling and induration (5%), skin pigmentation (5%), deep vein thrombosis (1%), erythema (1%), and bleeding (1%). The mean visual analog pain score for the entire procedure was 3.14±1.06.


Our short- and mid-term results of the EVLA procedure were satisfactory, and the results of this study reaffirmed the safety and effectiveness of an EVLA using a 940 nm wavelength for the treatment of GSV insufficiency.

EISSN 1305-3612